Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BDSI

BioDelivery Sciences International (BDSI) Stock Price, News & Analysis

BioDelivery Sciences International logo

About BioDelivery Sciences International Stock (NASDAQ:BDSI)

Advanced Chart

Key Stats

Today's Range
$5.59
$5.60
50-Day Range
$5.54
$5.60
52-Week Range
$2.50
$5.62
Volume
2.09 million shs
Average Volume
3.34 million shs
Market Capitalization
$577.05 million
P/E Ratio
6.74
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BDSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioDelivery Sciences International and its competitors with MarketBeat's FREE daily newsletter.

BDSI Stock News Headlines

Florida International University
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Science
Jim Cramer's Top Stock Picks: DF MNST BDSI
See More Headlines

BDSI Stock Analysis - Frequently Asked Questions

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) posted its quarterly earnings data on Tuesday, November, 2nd. The specialty pharmaceutical company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.01. The specialty pharmaceutical company earned $41.09 million during the quarter, compared to analyst estimates of $42.05 million. BioDelivery Sciences International had a trailing twelve-month return on equity of 21.25% and a net margin of 50.90%.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioDelivery Sciences International investors own include NVIDIA (NVDA), Bristol Myers Squibb (BMY), TG Therapeutics (TGTX), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
11/02/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:BDSI
CIK
1103021
Employees
200
Year Founded
1997

Profitability

Trailing P/E Ratio
6.74
Forward P/E Ratio
14.71
P/E Growth
N/A
Net Income
$84.86 million
Pretax Margin
17.77%

Debt

Sales & Book Value

Annual Sales
$166.70 million
Cash Flow
$0.36 per share
Price / Cash Flow
15.42
Book Value
$1.90 per share
Price / Book
2.94

Miscellaneous

Free Float
92,927,000
Market Cap
$577.05 million
Optionable
Optionable
Beta
0.56

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BDSI) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners